Investigations of bones of transgenic mice over expressing human human osteob stimulating factor-1 (OSF-1).

对过度表达人骨刺激因子-1 (OSF-1) 的转基因小鼠骨骼的研究。

基本信息

项目摘要

We have isolated osteoblast stimulating factor-1 (osf-1), that expressed in osteoblasts, and made transgenic mice over expressing osf-1 to investigate the effect to isotopic osteogenesis. Osf-1 over-expressing transgenic mice increased in bone mineral content, bone mineral density, and bone strength than wild type mice. Ovariectomized osf-1 over expressing mice, which are model of osteoporosis caused by estrogen deficiency, kept as the same bone volume as the sham operated wild type mice.Mating male mice expressing homozyous osf-1, with wild type female mice, we got osf-1 heterozygous littermates. Next, we mated the heterozygous male and the heterozygous female littermates, and got another littermates which had osf-1 gene or not. We used 108 female littermates to examine the bone strength. 14-week-old mice were operated, half number of them were ovariectomized and another half number of them were sham-operated. As a result, we gained 42 mice having transgene and ovariectomized, 11 mice having no transgene and ovariectomized, 46 mice having transgene and sham-operated, 9 mice being negative with transgene and sham-operated. We excised femora of these mice at the age of 28-week-old, and evaluated their failure load of whole femora by three point bending test. The span between the supprts was 9 mm long, and the cross-head-speed was 0.5 mm/min.In sham-operated mice groups, comparing with the transgenic mice and the wild type mice, by the value of failure load/body weight^2/3, the value of the transgenic mice tend to be stronger than that of the wild ones. (p=0.2175) Failure load per unit cross was approximated by that per body weight^2/3.We can suggest the posibility that osf-1 over expression transgenic mice with increasing bone volume are also increasing their bone strength.
我们分离了在成骨细胞中表达的成骨细胞刺激因子-1 (osf-1),并构建过表达osf-1的转基因小鼠,研究其对同位素成骨的影响。Osf-1过表达转基因小鼠骨矿物质含量、骨矿物质密度和骨强度均高于野生型小鼠。去卵巢osf-1过表达小鼠作为雌激素缺乏所致骨质疏松模型,其骨体积与假手术野生型小鼠相同。表达osf-1纯合子的雄鼠与野生型雌鼠交配,得到osf-1杂合子的仔鼠。然后,我们将杂合的雄性和杂合的雌性交配,得到另一个携带或不携带osf-1基因的幼崽。我们使用了108只雌窝来检查骨骼强度。对14周龄小鼠进行手术,其中一半切除卵巢,另一半假手术。结果得到转基因去卵巢小鼠42只,未转基因去卵巢小鼠11只,转基因假手术小鼠46只,转基因假手术阴性小鼠9只。我们在28周龄时切除这些小鼠的股骨,并通过三点弯曲试验评估其整个股骨的破坏负荷。支座之间的跨度为9mm,交叉速度为0.5 mm/min。在假手术小鼠组中,与转基因小鼠和野生型小鼠相比,在失效负荷/体重^2/3值上,转基因小鼠的失效负荷比野生型小鼠更强。(p=0.2175)每单位交叉的失效载荷近似为每体重的2/3。我们可以推测osf-1过表达转基因小鼠骨体积增加的同时骨强度也增加的可能性。

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hashimoto-Gotoh T, Yamaguchi M, Yasojima K, Tsujimura A, Wakabayashi Y., Watanabe Y: "A set of temperature sensitive-replication/-segregation and temperature resistant plasmid vectors with different copy numbers and in an isogenic background"Gene. 241. (2
Hashimoto-Gotoh T、Yamaguchi M、Yasojima K、Tsujimura A、Wakabayashi Y.、Watanabe Y:“一组具有不同拷贝数和等基因背景的温度敏感复制/分离和耐温质粒载体”基因。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Tamotsu Hashimoto Gotoh.et al: "A set of temperature sensitive-replication/-segregation and temperature resistant plasmid vectors with different copy"GENE. 241. 185-191 (2000)
Tamotsu Hashimoto Gotoh.et al:“一组具有不同拷贝的温度敏感复制/分离和耐温质粒载体”GENE。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
橋本保,増田治史,山口美樹,辻村敦,中村利孝,平澤泰介,中川雅夫 他3名: "ヒト骨芽細胞刺激因子(h-OSF1)による骨粗鬆症遺伝子治療の可能性"オステオポローシスジャパン. 9巻2号(印刷中). (2001)
Tamotsu Hashimoto、Osamu Masuda、Miki Yamaguchi、Atsushi Tsujimura、Toshitaka Nakamura、Taisuke Hirasawa、Masao Nakakawa 和其他 3 人:“使用人成骨细胞刺激因子 (h-OSF1) 进行骨质疏松症基因治疗的可能性”Osteoporosis Japan 第 9 卷第 2 期(正在出版)(2001)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hashimoto-Gotoh T,Yamaguchi M,Yasojima K,Tsujimura A,Watanabe Y: "A set of temperature sensitive-replication/-segregation and temperature resistant plasmid vectors with different copy numbers and in an isogenic background"Gene. 241-1. 185-91 (2000)
Hashimoto-Gotoh T、Yamaguchi M、Yasojima K、Tsujimura A、Watanabe Y:“一组具有不同拷贝数和等基因背景的温度敏感复制/分离和耐温质粒载体”基因。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hashimoto-Gotoh T, Masuda H, Yamaguchi M, Tsujimura A, Ohnishi H, Inoue K, Nakamura T, Hirasawa Y, Nakagawa M: "Possibility of gene therapy for osteoporosis by human Osteoblast Stimulating Factor (H-OSF1)"Osteoporosis Japan. (in press). (2001)
Hashimoto-Gotoh T、Masuda H、Yamaguchi M、Tsujimura A、Ohnishi H、Inoue K、Nakamura T、Hirasawa Y、Nakakawa M:“人类成骨细胞刺激因子 (H-OSF1) 基因治疗骨质疏松症的可能性”日本骨质疏松症。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HASHIMOTO-GOTOH Tamotsu其他文献

HASHIMOTO-GOTOH Tamotsu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HASHIMOTO-GOTOH Tamotsu', 18)}}的其他基金

Development of selective culture and cell plantation systems for mouse osteoblasts over-expressing human osteoblast stimulating factor-1 (OSF1)
开发过表达人成骨细胞刺激因子-1 (OSF1) 的小鼠成骨细胞的选择性培养和细胞种植系统
  • 批准号:
    14571393
  • 财政年份:
    2002
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on the gene expression of OSF-1 in osteoblasts derived from normal and osteoporosis patients.
正常和骨质疏松患者成骨细胞中 OSF-1 基因表达的研究。
  • 批准号:
    04836021
  • 财政年份:
    1992
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

miRNA靶位点遗传多态性调控骨质疏松机理研究
  • 批准号:
    31071097
  • 批准年份:
    2010
  • 资助金额:
    36.0 万元
  • 项目类别:
    面上项目

相似海外基金

Virtual Mouse and Human Twins for optimising Treatments for Osteoporosis
虚拟小鼠和人类双胞胎用于优化骨质疏松症的治疗
  • 批准号:
    EP/Z000203/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Research Grant
Optimizing osteoporosis diagnosis through opportunistic computed tomography: developing an implementation strategy for early detection and intervention.
通过机会性计算机断层扫描优化骨质疏松症诊断:制定早期检测和干预的实施策略。
  • 批准号:
    484646
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
    Fellowship Programs
Bone health management through exercise in older adults with diabetes: Patient perspectives and experiences
通过锻炼对患有糖尿病的老年人进行骨骼健康管理:患者的观点和经验
  • 批准号:
    497897
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Bioinformatics Core
生物信息学核心
  • 批准号:
    10404414
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
The role of osteoblast progenitors in response to bone anabolic agents
成骨细胞祖细胞对骨合成代谢剂的反应的作用
  • 批准号:
    10404415
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
骨质疏松症骨合成代谢疗法研究转化中心
  • 批准号:
    10404412
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10404413
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Mechanistic investigation into Frizzled-2 signaling for treatment of Osteogenesis Imperfecta
Frizzled-2 信号传导治疗成骨不全症的机制研究
  • 批准号:
    10680236
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
Mechanisms of osteocyte induction and regulation of pathogen-induced osteolysis
骨细胞诱导机制和病原体引起的骨溶解的调节
  • 批准号:
    10648513
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
The Role of Bone Sialoprotein in Modulating Periodontal Development and Repair
骨唾液酸蛋白在调节牙周发育和修复中的作用
  • 批准号:
    10752141
  • 财政年份:
    2023
  • 资助金额:
    $ 1.98万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了